This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
insurance-premium: Archive
UnitedHealth vs. Centene: Which Managed Care Stock Is the Better Buy?
by Rajshree Sipani
UNH's diversified platform, AI expansion and Optum momentum strengthen its long-term outlook, making it the stronger managed care pick over CNC.
UNHNegative Net Change CNCPositive Net Change
artificial-intelligence automation cancer healthcare hmo hospitals insurance insurance-premium medical pharmaceuticals smart-health staffing
Can These 3 Insurance Trends Fuel Accelerant's Growth Story?
by Kaibalya Pravo Dey
ARX is benefiting from AI, third-party capital and fronting trends, but investors still await proof that these drivers can deliver lasting diversification.
ARXPositive Net Change RYANPositive Net Change SKWDPositive Net Change
finance insurance insurance-premium
UnitedHealth vs. Humana: Which Healthcare Leader Is a Better Bet Now?
by Rajshree Sipani
UNH's diversified platform, AI investments and stronger earnings outlook give it an edge over Medicare-focused rival HUM.
UNHNegative Net Change HUMNegative Net Change
artificial-intelligence automation dividend dividend-yield healthcare hmo hospitals insurance insurance-premium medical smart-health
UnitedHealth Stock Jumps 20% YTD: Should Investors Jump in Too?
by Kaibalya Pravo Dey
UNH has surged 20% this year, but with valuation rising and investigations ongoing, is the easy money already gone?
UNHNegative Net Change HUMNegative Net Change ELVNegative Net Change
healthcare hmo insurance insurance-premium medical
UnitedHealth vs. Molina: Which Managed Care Stock Is the Better Bet?
by Rajshree Sipani
MOH's Medicaid focus, dual-eligible expansion and stronger share gains make it stand out against UNH in managed care.
UNHNegative Net Change MOHPositive Net Change
artificial-intelligence dental dividend healthcare hmo hospitals insurance insurance-premium medical pharmaceuticals smart-health staffing
UnitedHealth vs. Elevance: Which Healthcare Stock Has More Upside?
by Rajshree Sipani
UNH's integrated Optum engine and earnings stability give it an edge over ELV as shifting costs and policy changes reshape managed care dynamics.
UNHNegative Net Change ELVNegative Net Change
artificial-intelligence healthcare hmo hospitals insurance insurance-premium medical smart-health
Is Skyward Stock a Buy After the Pullback and Higher Leverage?
by Kaibalya Pravo Dey
SKWD's pullback raises questions as leverage climbs post-Apollo, but strong earnings, growth outlook and improving underwriting keep the long-term case intact.
ALLNegative Net Change HRTGNegative Net Change SKWDPositive Net Change
finance insurance insurance-premium
How Skyward's Niche Playbook Shields it From Pricing Pressure & Cycles
by Kaibalya Pravo Dey
SKWD leans on niche underwriting and new fee income streams to defend pricing power and sustain growth through shifting insurance cycles.
ALLNegative Net Change HCINegative Net Change HRTGNegative Net Change SKWDPositive Net Change
finance insurance insurance-premium
UnitedHealth vs. Humana: Which Healthcare Stock Has More Upside Now?
by Rajshree Sipani
UNH's scale and diversified model are likely to offer stronger upside than HUM as rising medical costs test managed care margins.
UNHNegative Net Change HUMNegative Net Change
artificial-intelligence healthcare hmo insurance insurance-premium medical smart-health
UnitedHealth's Q4 Beat Can't Stop the Slide: Should You Let Go Now?
by Kaibalya Pravo Dey
UNH beats Q4 EPS, but the stock plunges 21.5% as medical costs spiked, margins sank, and Medicare reimbursement risk clouded its outlook.
UNHNegative Net Change MOHPositive Net Change CNCPositive Net Change
earnings-report earnings-surprise healthcare hmo insurance insurance-premium medical